Canada Goose (NYSE:GOOS) Given Underweight Rating at Barclays

Barclays reiterated their underweight rating on shares of Canada Goose (NYSE:GOOS) in a report published on Monday, Marketbeat reports. Barclays currently has a $8.00 target price on the stock, down from their prior target price of $10.00.

A number of other equities analysts have also weighed in on GOOS. The Goldman Sachs Group lowered their price target on shares of Canada Goose from $9.00 to $8.00 and set a “sell” rating on the stock in a research report on Tuesday, December 10th. Evercore ISI lowered their target price on Canada Goose from $13.00 to $10.00 and set an “in-line” rating on the stock in a report on Monday, February 10th. Three research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $10.20.

Canada Goose Price Performance

Shares of Canada Goose stock opened at $7.96 on Monday. The stock has a market capitalization of $770.09 million, a P/E ratio of 15.30, a PEG ratio of 1.00 and a beta of 1.35. The business has a 50 day simple moving average of $9.81 and a two-hundred day simple moving average of $10.13. Canada Goose has a 12 month low of $7.51 and a 12 month high of $14.75. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.01 and a quick ratio of 1.14.

Canada Goose (NYSE:GOOS) last posted its quarterly earnings data on Thursday, February 6th. The company reported $1.10 EPS for the quarter, meeting the consensus estimate of $1.10. Canada Goose had a return on equity of 22.49% and a net margin of 5.47%. As a group, analysts predict that Canada Goose will post 0.7 EPS for the current fiscal year.

Institutional Trading of Canada Goose

Several hedge funds have recently made changes to their positions in the company. Patient Capital Management LLC lifted its holdings in Canada Goose by 3.4% in the fourth quarter. Patient Capital Management LLC now owns 3,854,520 shares of the company’s stock valued at $38,661,000 after acquiring an additional 128,133 shares during the last quarter. Arrowstreet Capital Limited Partnership acquired a new position in shares of Canada Goose in the 4th quarter valued at $12,251,000. Scheer Rowlett & Associates Investment Management Ltd. grew its holdings in shares of Canada Goose by 1.2% during the 4th quarter. Scheer Rowlett & Associates Investment Management Ltd. now owns 1,218,326 shares of the company’s stock worth $12,223,000 after purchasing an additional 14,341 shares during the period. Penn Capital Management Company LLC acquired a new stake in shares of Canada Goose during the 4th quarter worth about $5,702,000. Finally, Portolan Capital Management LLC purchased a new stake in Canada Goose in the 4th quarter valued at about $4,403,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

About Canada Goose

Canada Goose Holdings Inc, together with its subsidiaries, designs, manufactures, and sells performance luxury apparel for men, women, youth, children, and babies in Canada, the United States, Asia Pacific, Europe, the Middle East, and Africa. The company operates through three segments: Direct-to-Consumer, Wholesale, and Other.